By Thursday, Theranos had scrubbed its website of its list of blood-testing “wellness centers” and the glowing reviews by patients praising its minimally invasive method. Rather than selling low-priced lab tests to consumers, Theranos is now focusing its “undivided attention” on developing a portable blood-testing device it calls the miniLab, Holmes wrote in a letter. The boxes would serve as remote medical testing stations, perhaps set up in doctor’s offices, and be controlled from a central lab. Holmes had little choice but to leave the business of operating blood testing labs. “We are fortunate to have supporters and investors who believe deeply in our mission of affordable, less invasive lab testing, and to have the runway to realize our vision,” she added.

Source: Los Angeles Times October 06, 2016 22:53 UTC